Esperion Therapeutics surges on upbeat Q1 results

Esperion Therapeutics

07/05/2024 12:58

** Esperion Therapeutics shares  ESPR.O  jump 22% to $2.6
premarket after pharmaceutical firm posts upbeat Q1 results
    ** Stock to hit a near one-month high, if gains hold through
open
    ** Co reports Q1 rev of $137.7 mln, surpassing analyst
expectations of $83.7 mln - LSEG
    ** ESPR's Q1 profit of $61 mln also beats Street estimates
of $6.5 mln - LSEG
    ** Co saw a surge in "collaboration revenue", driven by
increased sales to international partners 
    ** Five of eight brokerages rate the stock "buy" or higher
and three "hold"; their median PT is $8 - LSEG data
    ** Up to last close, stock had fallen 29% YTD 

 (Reporting by Johann M Cherian in Bengaluru)
 ((johann.mcherian@thomsonreuters.com;))